Clinical Trial Update: DFD01 Spray HPA Axis Suppression Study in Adolescent Patients With Moderate to Severe Plaque Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 trial update for DFD01 spray in adolescents with moderate to severe plaque psoriasis has been terminated; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• DFD01 Spray

Snippet

Sponsor: Primus Pharmaceuticals | Conditions: Plaque Psoriasis | Phase 3 | Status: TERMINATED | Results posted: 2021-10-21